Search

everythinglearnresearchcommunity

for

Search:↓

Higher androgen levels might make COVID-19 worse, especially in men.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Mutations in certain receptors can cause diseases and offer new treatment options.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

The document explains various skin conditions and their treatments.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Minoxidil helps protect and rebuild elastic fibers in arteries, improving artery function, especially in older females.

Immune cells are crucial for hair growth and preventing hair loss.

SOX4 is crucial for the development of melanoma.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.